Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Srdan Verstovsek Uwe Platzbecker Jean-Jacques Kiladjian |
| Publication date | December 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |